Incipient intranuclear inclusion body disease in a 78-year-old woman

Fumiaki Mori, Yasuo Miki, Kunikazu Tanji, +4

Neuropathology

Lysosomal Storage DiseasePathologyIntranuclear InclusionsIncipient CaseHuman Pathology +15

Effects of estradiol on regulation of corticotropin-releasing factor gene and interleukin-6 production via estrogen receptor type β in hypothalamic 4B cells

Eriko Ogura, Kazunori Kageyama, Komaki Hanada, +2

Peptides

Endocrine MechanismHypothalamic 4BHormonal ReceptorPhysiologyNeuroendocrine Mechanism +6

Development of Tumor-induced Osteomalacia in a Subcutaneous Tumor, Defined by Venous Blood Sampling of Fibroblast Growth Factor-23

Eriko Ogura, Kazunori Kageyama, Seiji Fukumoto, +5

Internal Medicine

Fgf-23 LevelsPathologySubcutaneous TumorOrthopaedic SurgeryOsteoporosis +19

Comparison of Hospitalization Incidence in Influenza Outpatients Treated With Baloxavir Marboxil or Neuraminidase Inhibitors: A Health Insurance Claims Database Study

Takuji Komeda, Takahiro Takazono, Naoki Hosogaya, +11

Clinical Infectious Diseases

Safety and effectiveness of baloxavir marboxil for the treatment of influenza in Japanese clinical practice: A postmarketing surveillance of more than 3000 patients

Masami Nakazawa, Kanae Hara, Takuji Komeda, +1

Journal of Infection and Chemotherapy

PharmacotherapyFlu VaccinationInfluenza VaccinesPreventive MedicineBaloxavir Marboxil +14

High blood pressure lowered by pregnancy

Takehiko Murakami, Eriko Ogura, Yuji Tanaka, +1

The Lancet

HypertensionHigh Blood PressureMaternal Cardiovascular OutcomeGestational HypertensionGynecology +8

Mutations in type I collagen genes in Japanese osteogenesis imperfecta patients

Kyoko Kataoka, Eriko Ogura, Kosei Hasegawa, +4

Pediatrics International

Comparison of Household Transmission of Influenza Virus From Index Patients Treated With Baloxavir Marboxil or Neuraminidase Inhibitors: A Health Insurance Claims Database Study

Takuji Komeda, Takahiro Takazono, Naoki Hosogaya, +10

Clinical Infectious Diseases

Obesity in hospitalized type 2 diabetes patients: A descriptive study

Eriko Ogura

Medical Science Monitor

Clinical Drug-Drug Interaction Studies to Evaluate the Effects of a P-Glycoprotein Inhibitor, CYP3A Inhibitors, and a CYP3A Inducer on the Pharmacokinetics of Naldemedine in Healthy Subjects

Kazuya Fukumura, Nao Kawaguchi, Tôru Ishibashi, +3

Clinical Drug Investigation